The days of “two-day shipping” for abortion pills just hit a snag. The U.S. Court of Appeals for the Fifth Circuit has temporarily halted the use of telehealth to prescribe the abortion drug mifepristone, effectively shutting down the “order online, take it at home” model – for now. Mifepristone is the primary drug used in medication abortions.
The restriction stays put while the case crawls through the courts, unless the FDA runs to the U.S. Supreme Court for an emergency save. In the meantime, the appeals court just yanked the Biden-era rule that turned abortion pills into a mail-order commodity – meaning no more telehealth prescriptions and no more “add to cart” deliveries of mifepristone nationwide, at least for now.
And here’s the kicker: telehealth isn’t just some fringe workaround – more than 27% of abortions in the first half of 2025 were handed out through virtual appointments. Turns out that “add to cart” option to kill babies had become a pretty popular option.
Michigan Democratic Governor Gretchen Whitmer wasn’t thrilled about the court’s decision, calling the ruling “dangerous” and accusing opponents of playing politics over science. She doubled down on Michigan’s pro-abortion stance, promising to keep the mitten state a safe harbor for reproductive access.
Critics, meanwhile, argue the decision [1] reins in a Wild West approach to powerful drugs being handed out over a screen, raising safety and oversight concerns that go beyond convenience.
In the court’s ruling states, “The public interest is not served by perpetuating a medical practice whose safety the agency admits was inadequately studied.”
For now, the “click-to-end-it” model to get rid of unwanted babies just got pulled from the digital shelves. No quick checkout, no discreet delivery, no easy button. Call it a legal timeout or a reality check – but the court’s message is blunt: this isn’t Amazon, and not everything should be one-click away.